|
|
Article: ADHD drugs don't need `black box' warning, advisory panel says.
- Article from:
- The Philadelphia Inquirer (Philadelphia, PA)
- Article date:
- March 22, 2006
- Author:
CopyrightCOPYRIGHT 2006 The Philadelphia Inquirer. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: Thomas Ginsberg
PHILADELPHIA _ Drug-safety experts Wednesday rejected slapping a stern "black box" warning about psychiatric side effects on attention deficit/hyperactivity disorder drugs.
Still, the advisers to the Food and Drug Administration called on doctors and parents to be far more vigilant about the psychiatric side effects, citing rare but serious cases of horrific hallucinations, aggression and suicides by children.
The recommendation by the FDA's Pediatric Advisory Committee came nearly two months after another FDA advisory committee narrowly approved the idea of an black box on ADHD drug cardiovascular risks.
The ...